[1]卢志辉,张臣,马晓海.经皮球囊肺动脉成形术在治疗慢性血栓栓塞性肺动脉高压中的进展[J].介入放射学杂志,2025,34(03):324-328.
LU Zhihui,ZHANG Chen,MA Xiaohai..Advances in percutaneous balloon pulmonary angioplasty for the treatment of chronic thromboembolic pulmonary hypertension[J].journal interventional radiology,2025,34(03):324-328.
点击复制
经皮球囊肺动脉成形术在治疗慢性血栓栓塞性肺动脉高压中的进展(
)
《介入放射学杂志》[ISSN:1008-794X/CN:31-1796/R]
- 卷:
-
34
- 期数:
-
2025年03
- 页码:
-
324-328
- 栏目:
-
综述
- 出版日期:
-
2025-03-25
文章信息/Info
- Title:
-
Advances in percutaneous balloon pulmonary angioplasty for the treatment of chronic thromboembolic pulmonary hypertension
- 作者:
-
卢志辉; 张臣; 马晓海
-
- Author(s):
-
LU Zhihui; ZHANG Chen; MA Xiaohai.
-
Department of Interventional Diagnosis and Treatment,Beijing Anzhen Hospital,Capital Medical University,Beijing 100029,China
-
- 关键词:
-
【关键词】经皮球囊肺动脉成形术; 慢性血栓栓塞性肺动脉高压; 介入治疗
- 文献标志码:
-
A
- 摘要:
-
【摘要】慢性血栓栓塞性肺动脉高压(CTEPH)是一种可能危及生命的肺血管疾病,属于2022年欧洲心脏病学会指南中定义的第四大类肺动脉高压。经皮球囊肺动脉成形术(BPA)是一种在肺动脉造影引导下对狭窄部位进行连续及阶段性扩张的介入技术,为无法完成外科治疗或外科术后残余肺动脉高压的患者提供了全新的诊疗方法。该文将从BPA发展过程、适应证演进、操作技术发展等方面来介绍BPA这一介入技术及其在治疗CTEPH中的进展。
参考文献/References:
[1]Kim NH,Delcroix M,Jenkins DP,et al.Chronic thromboembolic pulmonary hypertension[J].J Am Coll Cardiol,2013,62:D92-D99.
[2]Mullin CJ,Klinger JR.Chronic thromboembolic pulmonary hypertension[J].Heart Fail Clin,2018,14:339-351.
[3]Lang I,Meyer BC,Ogo T,et al.Balloon pulmonary angioplasty in chronic thromboembolic pulmonary hypertension[J].Eur Respir Rev,2017:160119.
[4]Feinstein JA,Goldhaber SZ,Lock JE,et al.Balloon pulmonary angioplasty for treatment of chronic thromboembolic pulmonary hypertension[J].Circulation,2001,103:10-13.
[5]Mizoguchi H,Ogawa A,Munemasa M,et al.Refined balloon pulmonary angioplasty for inoperable patients with chronic thromboembolic pulmonary hypertension[J].Circ Cardiovasc Interv,2012,5:748-755.
[6]Kennedy MK,Kennedy SA,Tan KT,et al.Balloon pulmonary angioplasty for chronic thromboembolic pulmonary hypertension:a systematic review and meta-analysis[J].Cardiovasc Intervent Radiol,2023,46:5-18.
[7]Humbert M,Kovacs G,Hoeper MM,et al.ESC/ERS scientific document group.2022 ESC/ERS guidelines for the diagnosis and treatment of pulmonary hypertension[J].Eur Heart J,2022,43:3618-3731.
[8]Kawakami T,Matsubara H,Shinke T,et al.Balloon pulmonary angioplasty versus riociguat in inoperable chronic thromboembolic pulmonary hypertension (MR BPA):an open-label,randomised controlled trial[J].Lancet Respir Med,2022,10:949-960.
[9]Jais X,Brenot P,Bouvaist H,et al.Balloon pulmonary angioplasty versus riociguat for the treatment of inoperable chronic thromboembolic pulmonary hypertension (RACE):a multicentre,phase 3,open-label,randomised controlled trial and ancillary follow-up study[J].Lancet Respir Med,2022,10:961-971.
[10]王金志,陶新曹,谢万木,等.球囊肺动脉成形术治疗近端慢性血栓栓塞性肺动脉高压的安全性和有效性[J].介入放射学杂志,2023,32:746-749.
[11]Pang W,Zhang Z,Wang Z,et al.Higher incidence of chronic thromboembolic pulmonary hypertension after acute pulmonary embolism in asians than in europeans:a meta-analysis[J].Front Med (Lausanne),2021,8:721294.
[12]Velázquez M,Maneiro N,Lareo A,et al.Selective segmental pulmonary angiography:anatomical,technical and safety aspects of a must-learn technique in times of balloon pulmonary angioplasty for chronic thromboembolic pulmonary hypertension[J].J Clin Med,2021,10:3358.
[13]杜发旺,张萍,吴强,等.经皮球囊肺血管成形术治疗慢性血栓栓塞性肺动脉高压患者2例[J].介入放射学杂志,2022,31:627-629.
[14]Karyofyllis P,Demerouti E,Giannakoulas G,et al.Balloon pulmonary angioplasty in patients with chronic thromboembolic pulmonary hypertension in Greece:data from the Hellenic pulmonary hypertension registry[J].J Clin Med,2022,11:2211.
[15]Kataoka M,Inami T,Kawakami T,et al.Balloon pulmonary angioplasty (percutaneous transluminal pulmonary angioplasty) for chronic thromboembolic pulmonary hypertension:a Japanese perspective[J].JACC Cardiovasc Interv,2019,12:1382-1388.
[16]Inami T,Kataoka M,Shimura N,et al.Pulmonary edema predictive scoring index (Pepsi),a new index to predict risk of reperfusion pulmonary edema and improvement of hemodynamics in percutaneous transluminal pulmonary angioplasty[J].JACC Cardiovasc Interv,2013,6:725-736.
[17]Kawakami T,Ogawa A,Miyaji K,et al.Novel angiographic classification of each vascular lesion in chronic thromboembolic pulmonary hypertension based on selective angiogram and results of balloon pulmonary angioplasty[J].Circ Cardiovasc Interv,2016,9:e003318.
[18]Kaldararova M,Simkova I,Bohacekova M,et al.Central versus Peripheral CTEPH-Clinical and Hemodynamic Specifications[J].Medicina (Kaunas),2022,58:1538.
[19]Kawakami T,Kataoka M,Arai T,et al.Retrograde approach in balloon pulmonary angioplasty:useful novel strategy for chronic total occlusion lesions in pulmonary arteries[J].JACC Cardiovasc Interv,2016,9:e19-e20.
[20]Marukyan N,Simakova M,Moiseeva O,et al.Transbronchial guidance for balloon pulmonary angioplasty in CTEPH:the safe guidewire passage through the occlusion[J].JACC Cardiovasc Interv,2022,15:e25-e26.
[21]Yang T,Li X,Luo Q,et al.Angiographic classification of total occlusion and its implication on balloon pulmonary angioplasty[J].ESC Heart Fail,2024,11:795-804.
[22] Ghofrani HA,Kim NH.Medical and interventional therapies for inoperable CTEPH:a necessary combination?[J].Lancet Respir Med,2022,10:926-927.
[23]Yanaka K,Nakayama K,Shinke T,et al.Sequential hybrid therapy with pulmonary endarterectomy and additional balloon pulmonary angioplasty for chronic thromboembolic pulmonary hypertension[J].J Am Heart Assoc,2018,7:e008838.
[24]Tsukada J,Yamada Y,Kawakami T,et al.Treatment effect prediction using CT after balloon pulmonary angioplasty in chronic thromboembolic pulmonary hypertension[J].Eur Radiol,2021,31:5524-5532.
[25]汪薇,龚娟妮,王剑锋,等.逐步肺动脉球囊扩张成形术治疗慢性血栓栓塞性肺动脉高压血流动力学变化的研究[J].中华结核和呼吸杂志,2024,47:120-125.
[26]Suruga K,Shimokawahara H,Miyagi A,et al.Flow grade-based success rates,complication rates,and balloon pulmonary angioplasty patency for total occlusions[J].Can J Cardiol,2023:S0828-282X(23)01974.
[27]Takigami M,Tsubata H,Nakanishi N,et al.The effectiveness of scoring balloon angioplasty in the treatment of chronic thromboembolic pulmonary hypertension[J].PLoS One,2022,17:e0263244.
[28]Matsukawa R,Kozai T,Tokutome M,et al.Plaque modification using a cutting balloon is more effective for stenting of heavily calcified lesion than other scoring balloons[J].Cardiovasc Interv Ther,2019,34:325-334.
[29]Souteyrand G,Amabile N,Mangin L,et al.Mechanisms of stent thrombosis analysed by optical coherence tomography:insights from the National PESTO French registry[J].Eur Heart J,2016,37:1208-1216.
[30]Hong C,Luo FQ,Liu CL,et al.Clinical study of optical coherence tomography in the diagnosis of peripheral pulmonary artery thrombus[J].Thromb Res,2018,161:52-59.
[31]Gall H,Hoeper MM,Richter MJ,et al.An epidemiological analysis of the burden of chronic thromboembolic pulmonary hypertension in the USA,Europe and Japan[J].Eur Respir Rev,2017,26:160121.
[32]Bashir R,Noory A,Oliveros E,et al.Refined balloon pulmonary angioplasty in chronic thromboembolic pulmonary hypertension:initial results of U.S.regional program[J].JACC Adv,2023,2:100291.
备注/Memo
- 备注/Memo:
-
(收稿日期:2024-02-20)
(本文编辑:茹实)
更新日期/Last Update:
2025-03-25